Australia's largest stock trading and investment forum Australia's #1 stock forum

Interest Rates, page-2

First 2 Last

Share
Profile

Follow
lexcorp

8,015 Posts.

516

31/07/14

09:23

Post #: 13742871
Share

Originally posted by n5435137 ↑

From the AFR:
The Reserve Bank may be forced to cut the official cash rate before the end of the year to beat back of a wall of foreign money that has driven the Australian dollar higher, according to Goldman Sachs Asset Management’s bond expert Phil Moffitt.
Mr Moffitt, a 30-year veteran of the bond market and one of Goldman’s most senior Australian partners was speaking at the sidelines of the $935 billion asset managers’ client conference in Sydney.
He said the confluence of weak domestic growth, an expected fall in inflation as the carbon tax is discarded and the high currency was pointing towards a potential cut in the official rate cut below its current 2.50 per cent setting.
“The game plan has been the RBA to hold rates stable, and accept the currency is overvalued, in anticipation of the Fed moving [to lift US interest rates],” Mr Moffitt said.
“But the more the Fed works to pacify market expectations of a rate rise, the stronger the local currency gets and the harder it is for the RBA to manage,” he said.

Expand

The banks offering a better deal on fixed rates guaranteed this last week.
1 Upvote

Reply

Top Stories

TNC

True North increases silver metal at QLD's Vero deposit by 20%

Emerald & Azure score Digger & Dealer awards

Revolutionary inverter technology leads the clean energy charge

HZR

Hazer Group reports ten days of continuous operation at graphite-manufacturing test facility

Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling

Bitcoin: Current State of Play & Where to Next | Swyftx

From the Floor with Federal Opposition Leader Peter Dutton at Diggers & Dealers 2024

TKM

Trek Metals jumps 5% as gold & REE drill run kicks off at Christmas Creek in the Kimberley

Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market

NEU

Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress

There are more pages in this discussion • 16 more messages in this thread...

First 2 Last